These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23162127)

  • 61. MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.
    Park SM; Ko HJ; Shim DH; Yang JY; Park YH; Curtiss R; Kweon MN
    J Immunol; 2008 Nov; 181(9):6447-55. PubMed ID: 18941235
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses.
    Jossi SE; Arcuri M; Alshayea A; Persaud RR; Marcial-Juárez E; Palmieri E; Di Benedetto R; Pérez-Toledo M; Pillaye J; Channell WM; Schager AE; Lamerton RE; Cook CN; Goodall M; Haneda T; Bäumler AJ; Jackson-Jones LH; Toellner KM; MacLennan CA; Henderson IR; Micoli F; Cunningham AF
    Front Immunol; 2023; 14():1139329. PubMed ID: 37033932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
    Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
    Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of very-long O-antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi.
    Crawford RW; Wangdi T; Spees AM; Xavier MN; Tsolis RM; Bäumler AJ
    mBio; 2013 Jul; 4(4):. PubMed ID: 23860765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
    Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
    Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in mice.
    Fiorino F; Ciabattini A; Rondini S; Pozzi G; Martin LB; Medaglini D
    Vaccine; 2012 Sep; 30(43):6111-4. PubMed ID: 22705173
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
    Arya SC
    Vaccine; 1997 Feb; 15(2):244. PubMed ID: 9066045
    [No Abstract]   [Full Text] [Related]  

  • 69. Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.
    Acevedo R; Callicó A; Aranguren Y; Zayas C; Valdés Y; Pérez O; García L; Ferro VA; Pérez JL
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S10. PubMed ID: 23458379
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae.
    Shriner AK; Liu H; Sun G; Guimond M; Alugupalli KR
    J Immunol; 2010 Jul; 185(1):525-31. PubMed ID: 20505146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever].
    Paniagua J; Isibasi A; Pelayo R; Ortiz V; Muy M; González C; García JA; Islas S
    Arch Invest Med (Mex); 1989; 20(4):315-20. PubMed ID: 2488771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Experience with Vi typhoid capsular polysaccharide vaccine in the U.K.
    Arnold WS; Harcus AW; St Clair Roberts J; Ward AE
    J Infect; 1992 Jul; 25(1):63-6. PubMed ID: 1522324
    [TBL] [Abstract][Full Text] [Related]  

  • 74. IFN-γ-producing CD4+ T cells promote generation of protective germinal center-derived IgM+ B cell memory against Salmonella Typhi.
    Perez-Shibayama C; Gil-Cruz C; Pastelin-Palacios R; Cervantes-Barragan L; Hisaki E; Chai Q; Onder L; Scandella E; Regen T; Waisman A; Isibasi A; Lopez-Macias C; Ludewig B
    J Immunol; 2014 Jun; 192(11):5192-200. PubMed ID: 24778443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Typhoid Vi: a less reactogenic vaccine.
    Cumberland NS; St Clair Roberts J; Arnold WS; Patel RK; Bowker CH
    J Int Med Res; 1992 Jun; 20(3):247-53. PubMed ID: 1397669
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.
    Klugman KP; Koornhof HJ; Robbins JB; Le Cam NN
    Vaccine; 1996 Apr; 14(5):435-8. PubMed ID: 8735556
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.
    Ramirez K; Capozzo AV; Lloyd SA; Sztein MB; Nataro JP; Pasetti MF
    J Immunol; 2009 Jan; 182(2):1211-22. PubMed ID: 19124765
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply.
    Keddy KH; Klugman KP; Robbins JB
    Vaccine; 1998; 16(9-10):871-2. PubMed ID: 9682329
    [No Abstract]   [Full Text] [Related]  

  • 79. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
    Haque A
    Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter.
    Janis C; Grant AJ; McKinley TJ; Morgan FJ; John VF; Houghton J; Kingsley RA; Dougan G; Mastroeni P
    Infect Immun; 2011 Jun; 79(6):2481-8. PubMed ID: 21402763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.